Search results for "patient outcome assessment"

showing 8 items of 28 documents

The Qualification of Outcome after Cervical Spine Surgery by Patients Compared to the Neck Disability Index

2016

Contains fulltext : 168196.PDF (Publisher’s version ) (Open Access) OBJECTIVE: The Neck Disability Index (NDI) is a patient self-assessed outcome measurement tool to assess disability, and that is frequently used to evaluate the effects of the treatment of neck-related problems. In individualized medicine it is mandatory that patients can interpret data in order to choose a treatment. A change of NDI or an absolute NDI is generally meaningless to a patient. Therefore, a correlation between the qualification of the clinical situation rated by the patient and the NDI score was evaluated. METHODS: Patients who completed an NDI after anterior surgery because of symptomatic single level degenera…

MaleQuestionnairesCervical spine surgeryMedical DoctorsHealth Care ProvidersStress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13]Social Scienceslcsh:MedicineSeverity of Illness IndexOutcome (game theory)Disability EvaluationCognition0302 clinical medicineSociologyQuality of lifeSurveys and QuestionnairesMedicine and Health SciencesEthnicitiesPostoperative Periodlcsh:SciencePain Measurement030222 orthopedicsMultidisciplinaryMortality rateWomen's cancers Radboud Institute for Health Sciences [Radboudumc 17]ProfessionsAnterior surgerymedicine.anatomical_structureResearch DesignPreoperative PeriodCervical VertebraeFemaleResearch ArticleCervical vertebraemedicine.medical_specialtyPatientsDeath RatesDecision MakingSurgical and Invasive Medical ProceduresResearch and Analysis MethodsEducation03 medical and health sciencesPopulation MetricsPhysiciansSeverity of illnessmedicineHumansEducational AttainmentDemographyDutch PeopleSurvey ResearchPopulation Biologybusiness.industrylcsh:RBiology and Life SciencesPatient Outcome AssessmentHealth CareReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]ROC CurvePeople and PlacesQuality of LifePhysical therapyCognitive SciencePopulation Groupingslcsh:Qbusiness030217 neurology & neurosurgeryNeck Disability IndexNeuroscience
researchProduct

Dietary Polyphenol Intake is Associated with HDL-Cholesterol and A Better Profile of other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-…

2020

Dietary polyphenol intake is associated with improvement of metabolic disturbances. The aims of the present study are to describe dietary polyphenol intake in a population with metabolic syndrome (MetS) and to examine the association between polyphenol intake and the components of MetS. This cross-sectional analysis involved 6633 men and women included in the PREDIMED (PREvenci&oacute

Maleevaluación del desenlace del pacienteSíndrome metabòlicaMediterranean diet030309 nutrition & dieteticshumanosstilbenesDiet MediterraneanBody Mass Indexchemistry.chemical_compound0302 clinical medicinePublic Health SurveillanceFood scienceCompostos bioactiusmediana edad2. Zero hungerMetabolic Syndromeanciano0303 health scienceseducation.field_of_studyNutrition and Dieteticsdietafood and beveragescolesterolMiddle AgedMetabolic syndromeHDL-cholesterolCholesterolPolifenolsFemaleColesterollcsh:Nutrition. Foods and food supplyPopulationDietética y nutrición030209 endocrinology & metabolismlcsh:TX341-641Dietary PolyphenolBioactive compoundsArticle03 medical and health sciencesMediterranean cookingMediterranean dietCuina mediterràniamedicineHumansvigilancia en salud públicapolifenoleseducationNutricióNutritionAgedCholesterolbusiness.industryíndice de masa corporalCholesterol HDLPolyphenolsmedicine.diseaseDietPatient Outcome AssessmentBlood pressureglignansCross-Sectional StudieschemistryPolyphenolDietary SupplementsMetabolic syndromebusinessBody mass indexBiomarkersestudios transversalesFood ScienceNutrients
researchProduct

Usefulness of Clinical Data and Biomarkers for the Identification of Frailty After Acute Coronary Syndromes

2015

Abstract Background Frailty predicts mortality after acute coronary syndrome (ACS). The standard frailty scales, such as the Fried score, consist of a variety of questionnaires and physical tests. Our aim was to investigate easily available clinical data and blood markers to predict frailty at discharge, in elderly patients after ACS. Methods A total of 342 patients older than 65 years, survivors after ACS, were included. A high number of clinical variables were collected. In addition, blood markers potentially linked to frailty and related to the processes of inflammation, coagulation, hormonal dysregulation, nutrition, renal dysfunction, and heart dysfunction were determined. Frailty was …

Malemedicine.medical_specialtyAcute coronary syndromeFrail ElderlyMyocardial InfarctionComorbidityDiseaseCohort StudiesRisk FactorsInternal medicineVitamin D and neurologyHumansMedicineMyocardial infarctionAcute Coronary SyndromeCystatin CVitamin DGeriatric AssessmentAgedAged 80 and overbusiness.industryPrognosismedicine.diseaseComorbidityPatient DischargeSurgeryPatient Outcome AssessmentHeart failureHemoglobinometryBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesCohort studyCanadian Journal of Cardiology
researchProduct

Association between general and oral health-related quality of life in patients treated for oral cancer

2015

Background Less is known about the association between general health-related quality of life (HRQoL) and oral HRQoL (OHRQoL) among patients with specific diseases. The aim of this study was to assess the association between patient-centered outcome measurements (HRQoL and OHRQoL) of oral cancer patients at least 6 months after treatment. Material and Methods HRQoL was measured with the 12-Item Short Form Health Survey (SF-12); OHRQoL was evaluated using the Oral Health Impact Profile (OHIP-14) and the Oral Impacts on Daily Performances (OIDP). Results Higher OHRQoL scores were associated with lower SF-12 domains scores. The OHIP-14 explained 16.5 % of the total variance of SF-12 Physical C…

Malemedicine.medical_specialtyPediatricsTime FactorsPsychological interventionOral HealthOdontologíaOral healthQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansIn patientAssociation (psychology)General DentistryAgedMouth neoplasmOral Medicine and Pathologybusiness.industryResearchCancerMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludhumanitiesPatient Outcome Assessmentstomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeFemaleMouth NeoplasmsSurgerybusinessAfter treatment
researchProduct

Effects of a Home-Based Physical Rehabilitation Program on Physical Disability After Hip Fracture: A Randomized Controlled Trial

2015

Abstract Objective Fewer than half of the patients with hip fracture will regain the prefracture level of physical functioning. This secondary analysis of a randomized controlled trial investigated the effects of a multicomponent home-based rehabilitation program (ProMo) on physical disability after hip fracture. Design Randomized, controlled, parallel-group trial. Setting Rehabilitation in participants' homes; measurements in university-based laboratory and local hospital. Participants Population-based clinical sample of community-dwelling people older than 60 years (n = 81) operated for hip fracture were randomized into intervention and control groups. Intervention The year-long intervent…

Malemedicine.medical_specialtyPhysical disabilityActivities of daily livingADLmedicine.medical_treatmentPopulationproximal femoral fractureWalkingRisk AssessmentGeelaw.inventionDisability EvaluationInjury Severity ScorePhysical medicine and rehabilitationRandomized controlled triallawActivities of Daily LivingmedicineHumansMobility LimitationeducationGeriatric AssessmentIADLPhysical Therapy ModalitiesGeneral NursingAgedAged 80 and overHip fractureeducation.field_of_studyRehabilitationHip Fracturesbusiness.industryHealth Policyta3141Recovery of FunctionGeneral MedicineMiddle Agedmedicine.diseaseHome Care ServicesPatient Outcome AssessmentTreatment OutcomeSample size determinationPhysical therapyFemaleGeriatrics and GerontologybusinessFollow-Up StudiesJournal of the American Medical Directors Association
researchProduct

Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey

2013

BackgroundBone metastasis represents an increasing clinical problem in advanced gastric cancer (GC) as disease-related survival improves. In literature, few data on the natural history of bone disease in GC are available.Patients and methodsData on clinicopathology, skeletal outcomes, skeletal-related events (SREs), and bone-directed therapies for 208 deceased GC patients with evidence of bone metastasis were statistically analyzed.ResultsMedian time to bone metastasis was 8 months (CI 95%, 6.125-9.875 months) considering all included patients. Median number of SREs/patient was one. Less than half of the patients (31%) experienced at least one and only 4 and 2% experienced at least two and …

OncologyAdultMalemedicine.medical_specialtyPathologyBone diseaseSettore MED/06 - Oncologia Medicamedicine.medical_treatmentScienceBone NeoplasmsMetastasisgastric cancer; bone metastasisStomach NeoplasmsInternal medicinemedicineHumansskeletal disease advanced hepatocellular carcinomaskeletal-related events bisphosphonateAdult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Patient Outcome Assessment; Population Surveillance; Prognosis; Retrospective Studies; Stomach NeoplasmsNeoplasm Metastasisbone metastasisAgedRetrospective StudiesMultidisciplinaryBone Density Conservation AgentsDiphosphonatesbusiness.industrygastric cancerQRBone metastasisCancerBone fractureMiddle Agedmedicine.diseasePrognosisRadiation therapyPatient Outcome AssessmentBone Density Conservation AgentsZoledronic acidPopulation SurveillanceMedicineFemalebusinessmedicine.drugResearch Article
researchProduct

Results of nurse case management in primary heath care: Bibliographic review

2020

Background: The new characteristics of today&rsquo

SciELOAdultAdolescentHealth Toxicology and MutagenesisPopulationScopuslcsh:MedicineNursingpatient outcome assessmentArticleChronic diseaseScientific evidenceCase management03 medical and health sciences0302 clinical medicineQuality of life (healthcare)NursingnursingMedicineHumanscase management030212 general & internal medicinePatient outcome assessmentDuration (project management)educationAgededucation.field_of_study030504 nursingPrimary Health Carebusiness.industrylcsh:RPublic Health Environmental and Occupational HealthEmergency departmentCross-Sectional StudiesQuality of LifeFemaleEnfermería0305 other medical sciencebusinessInclusion (education)chronic diseaseFollow-Up Studies
researchProduct

Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic st…

2017

IF 7.702; International audience; The survival of patients with diffuse large B-cell lymphoma has increased during the last decade as a result of addition of anti-CD20 to anthracycline-based chemotherapy. Although the trend is encouraging, there are persistent differences in survival within and between the USA and European countries suggesting that non-biological factors play a role. Our aim was to investigate the influence of such factors on relative survival of patients with diffuse large B-cell lymphoma. We conducted a retrospective, multicenter, registry-based study in France on 1165 incident cases of diffuse large B-cell lymphoma between 2002 and 2008. Relative survival analyses were p…

[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/HematologyMale0301 basic medicinePediatricsMultivariate analysisMESH: RegistriesMESH : AgedMESH: ComorbidityComorbidityMESH : Lymphoma Large B-Cell DiffuseMESH: Aged 80 and over0302 clinical medicineInternational Prognostic IndexMESH : ChildMESH: ChildMESH : Population Surveillance[ SDV.MHEP.HEM ] Life Sciences [q-bio]/Human health and pathology/HematologyMESH : FemaleRegistriesYoung adultChildAged 80 and overMESH: AgedMESH: Middle AgedMESH : PrognosisRelative survivalMESH: Patient Outcome Assessment[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyArticlesHematologyMiddle AgedMESH : AdultPrognosisMESH : Patient Outcome Assessment3. Good healthMESH: Young AdultPopulation SurveillanceMESH: Survival Analysis030220 oncology & carcinogenesisMESH : ComorbidityMarital statusFemaleFranceLymphoma Large B-Cell DiffuseNon-Hodgkin LeukemiaAdultmedicine.medical_specialtyAdolescentMESH : MaleMESH: Factor Analysis StatisticalMESH : Young AdultMESH : Factor Analysis StatisticalMESH: PrognosisMESH: Population SurveillanceMESH: Social ClassYoung Adult03 medical and health sciencesMESH : AdolescentInternal medicineMESH : Social ClassmedicineHumansMESH : Middle AgedMESH : Aged 80 and overMESH : FranceSurvival analysisAgedMESH: AdolescentMESH: Humansbusiness.industryMESH : HumansMESH: Adultmedicine.diseaseSurvival AnalysisComorbidityMESH: MalePatient Outcome AssessmentMESH: France030104 developmental biologySocial ClassMESH: Lymphoma Large B-Cell DiffuseMESH : Survival AnalysisFactor Analysis StatisticalbusinessMESH: FemaleDiffuse large B-cell lymphomaMESH : RegistriesHaematologica
researchProduct